Breast Cancer :: Women prefer mastectomy, not lumpectomy
Concerned about cancer recurrence, women with breast cancer often choose a mastectomy over a less-drastic lumpectomy when they have control over the decision, a new study found.
Breast cancer
Breast Cancer :: Femara for postmenopausal women with breast cancer
Novartis has submitted marketing authorization applications in the United States and Europe for the use of Femara? (letrozole) in the adjuvant (post-surgery) treatment of postmenopausal women with hormone receptor-positive early breast cancer.
Breast Cancer :: Anastrozole – Arimidex – New drug for breast cancer
A drug shown to be more effective than the previous “gold standard” treatment for early-stage breast cancer sufferers becomes available to patients.
Breast Cancer :: At-Home Breast Cancer Detector Effective
A hand-held imaging device designed for use at home appears effective in detecting breast cancer in its early stages, according to a University of Pennsylvania researcher who hopes the device might be available commercially to women in a year or two.
Breast Cancer :: The Practical Guide to Breast Cancer
Having someone to talk with who has been there can make that mind-numbing diagnosis of breast cancer somewhat bearable.
Breast Cancer :: Guide for the Woman With Newly Diagnosed Breast Cancer
In a valuable guide for women who have just been diagnosed with breast cancer, Dr. John Link helps sort through the confusion and the fear, by explaining such things as how to get a second opinion and how to understand a pathology report.
Breast Cancer :: A Guide to Getting the Best Possible Treatment
Over the past decade, breast cancer advocates have encouraged women to learn about their disease and get involved in their treatment decisions.
Breast Cancer :: Japanese women show lower incidence of breast cancer recurrence
American women of Japanese descent treated for early-stage breast cancer are less likely to suffer a recurrence of the disease than women of other ancestries.
Breast Cancer :: Bevacizumab and chemotherapy improve breast cancer
Preliminary results from a large, randomized clinical trial for patients with previously untreated recurrent or metastatic breast cancer – cancer that has spread from the breast to other parts of the body – show that those patients who received bevacizumab (Avastin) in combination with standard chemotherapy had a longer time period before their cancer progressed than patients who received the same chemotherapy without bevacizumab.
Breast Cancer :: Breast Cancer study boosts Avastin
Biotech company Genentech Inc. and Swiss drug maker Roche Holding AG said that an interim analysis of clinical trial data showed that cancer treatment Avastin met its primary endpoint of increasing survival rates in breast cancer patients.